Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
J&J Snaps Six Straight Sessions of Losses
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Merck, Bristol-Myers Fail to Convince FDA AdCom on Wider Opdivo, Keytruda Use
Abbott Laboratories Analyst Ratings
Express News | CNBC Halftime Report Final Trades: Palo Alto Networks, Delta Air Lines, PayPal Holdings, SPDR Select Sector Fund - Health Care
BioAge Stock Rallies 29% Following Upsized $198M IPO
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
J&J to Shutter Cardiovascular, Metabolic Drug Unit: Report
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Tech Stocks Lead Rally
Telesis Bio Partners With Danaher Company Beckman Coulter
Evaxion Stock Jumps on Expanded Vaccine Development Pact With MSD
Evaxion Biotech Has Entered Into An Option And License Agreement With Merck For Two Preclinical Vaccine Candidates, For An Upfront Payment Of $3.2M And Up To $10M In 2025, If Merck Exercises Its Option To License Either One Or Both Candidates And...
Merck Announced That New Data Highlighting The Long-term Efficacy And Safety Of Tulisokibart (MK-7240) In Ulcerative Colitis And Crohn's Disease Will Be Presented At The United European Gastroenterology Week 2024 Congress
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
This Is What Whales Are Betting On Merck & Co
Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Stocks That Are Set to Benefit From Either Harris or Trump Winning Scenarios – Barclays
Next Frontier in Anti-obesity Landscape: Oral GLP-1s With Potential OTC Switch